plavix

Generic: clopidogrel

Labeler: sanofi-aventis u.s. llc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name plavix
Generic Name clopidogrel
Labeler sanofi-aventis u.s. llc
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

clopidogrel bisulfate 75 mg/1

Manufacturer
Sanofi-Aventis U.S. LLC

Identifiers & Regulatory

Product NDC 0024-1171
Product ID 0024-1171_ed60a9e7-49f4-469c-bb7a-08e1bb6057e2
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA020839
Listing Expiration 2026-12-31
Marketing Start 1997-11-17

Pharmacologic Class

Classes
cytochrome p450 2c8 inhibitors [moa] decreased platelet aggregation [pe] p2y12 platelet inhibitor [epc] p2y12 receptor antagonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00241171
Hyphenated Format 0024-1171

Supplemental Identifiers

RxCUI
213169 309362 749196 749198
UNII
08I79HTP27

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name plavix (source: ndc)
Generic Name clopidogrel (source: ndc)
Application Number NDA020839 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 75 mg/1
source: ndc
Packaging
  • 90 TABLET, FILM COATED in 1 BOTTLE (0024-1171-90)
source: ndc

Packages (1)

Ingredients (1)

clopidogrel bisulfate (75 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "ed60a9e7-49f4-469c-bb7a-08e1bb6057e2", "openfda": {"unii": ["08I79HTP27"], "rxcui": ["213169", "309362", "749196", "749198"], "spl_set_id": ["de8b0b67-eb25-4684-83b5-7ad785314227"], "manufacturer_name": ["Sanofi-Aventis U.S. LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE (0024-1171-90)", "package_ndc": "0024-1171-90", "marketing_start_date": "20200713"}], "brand_name": "Plavix", "product_id": "0024-1171_ed60a9e7-49f4-469c-bb7a-08e1bb6057e2", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cytochrome P450 2C8 Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "P2Y12 Platelet Inhibitor [EPC]", "P2Y12 Receptor Antagonists [MoA]"], "product_ndc": "0024-1171", "generic_name": "clopidogrel", "labeler_name": "Sanofi-Aventis U.S. LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Plavix", "active_ingredients": [{"name": "CLOPIDOGREL BISULFATE", "strength": "75 mg/1"}], "application_number": "NDA020839", "marketing_category": "NDA", "marketing_start_date": "19971117", "listing_expiration_date": "20261231"}